AJP - Renal Physiology, Vol 270, Issue 5 845-F851, Copyright © 1996 by American Physiological Society

ARTICLES

Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans

J. N. Bech, C. B. Nielsen and E. B. Pedersen
Research Laboratory for Hypertension and Nephrology, Skejby Hospital, University Hospital in Aarhus, Denmark.

Animal studies have implicated an important role of nitric oxide (NO) in the regulation of blood pressure, renal hemodynamics, and renal excretion of sodium. NG-monomethyl-L-arginine (L-NMMA) is a specific, competitive inhibitor of NO synthesis interfering with NO synthase. The purpose of the present study was to investigate the effect of L-NMMA on renal plasma flow (RPF), glomerular filtration rate (GFR), urinary sodium excretion (UNa), fractional sodium excretion (FENa), fractional lithium excretion (FELi), mean arterial blood pressure (MAP), and heart rate (HR) in healthy humans. In a randomized placebo-controlled study, 23 healthy subjects were randomized to receive either bolus injection of L-NMMA (3 mg/kg in 10 ml saline, n = 12 subjects) or placebo (10 ml saline, n = 11). GFR and RPF were measured using the renal clearances of 51Cr-labeled EDTA and 125I-labeled hippuran by the constant infusion technique. L-NMMA treatment induced 60 min after injection a 14.6% decrease in RPF, a 5.8% decrease in GFR, a 9.8% increase in filtration fraction, a 34.7% decrease in UNa a 28.6% decrease in FENa, and a 12.1% decrease in FELi. These changes were still evident 120 min after injection. None of the effect parameters were changed after placebo, except FENa, which increased 9.9% 60 min after injection. Ten minutes after L-NMMA injection, MAP increased significantly (80 vs. 88 mmHg), and HR decreased (58 vs. 47 beats/min). The changes in HR and MAP normalized within 30 min. L-NMMA significantly reduced the plasma level of cGMP 60 min (3.0 vs. 3.7 pmol/l) and 120 min after injection (2.5 vs. 3.7 pmol/l). It is concluded that, in healthy humans, NO is a regulator of renal hemodynamics as a tonic vasodilator and a regulator of sodium excretion, due at least in part to a proximal tubular effect.

This article has been cited by other articles:

				M. Graebe, L. Brond, S. Christensen, S. Nielsen, N. V. Olsen, and T. E. N. Jonassen Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats Am J Physiol Renal Physiol, February 1, 2004; 286(2): F288 - F297. [Abstract] [Full Text] [PDF]

				G. T. Dorner, G. Garhofer, B. Kiss, E. Polska, K. Polak, C. E. Riva, and L. Schmetterer Nitric oxide regulates retinal vascular tone in humans Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H631 - H636. [Abstract] [Full Text] [PDF]

				I. Pagel, T. Langenickel, K. Hohnel, S. Philipp, A. K. Nussler, W. F. Blum, M. L. Aubert, R. Dietz, and R. Willenbrock Cardiac and Renal Effects of Growth Hormone in Volume Overload-Induced Heart Failure: Role of NO Hypertension, January 1, 2002; 39(1): 57 - 62. [Abstract] [Full Text] [PDF]

				M. Liang, T. J. Berndt, and F. G. Knox Mechanism underlying diuretic effect of L-NAME at a subpressor dose Am J Physiol Renal Physiol, September 1, 2001; 281(3): F414 - F419. [Abstract] [Full Text] [PDF]

				G. Peer, E. Itzhakov, Y. Wollman, T. Chernihovsky, I. Grosskopf, D. Segev, D. Silverberg, M. Blum, D. Schwartz, and A. Iaina Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1436 - 1441. [Abstract] [Full Text] [PDF]

				F. Lo and S. Kaufman Effect of 5{alpha}-pregnan-3{alpha}-ol-20-one on nitric oxide biosynthesis and plasma volume in rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1902 - R1905. [Abstract] [Full Text] [PDF]

				L.-T. DIJKHORST-OEI, P. BOER, T. J. RABELINK, and H. A. KOOMANS Nitric Oxide Synthesis Inhibition Does Not Impair Water Immersion-Induced Renal Vasodilation in Humans J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1293 - 1302. [Abstract] [Full Text]

				M. Liang and F. G. Knox Production and functional roles of nitric oxide in the proximal tubule Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1117 - R1124. [Abstract] [Full Text] [PDF]

				A. Montanari, A. Biggi, N. Carra, E. Fasoli, M. Calzolari, F. Corsini, P. Perinotto, and A. Novarini Endothelin-A Blockade Attenuates Systemic and Renal Hemodynamic Effects of L-NAME in Humans Hypertension, January 1, 2000; 35(1): 518 - 523. [Abstract] [Full Text] [PDF]

				B. C. Kone and S. Higham Nitric oxide inhibits transcription of the Na+-K+-ATPase alpha 1-subunit gene in an MTAL cell line Am J Physiol Renal Physiol, April 1, 1999; 276(4): F614 - F621. [Abstract] [Full Text] [PDF]

				A. Broere, A. H. Van Den Meiracker, F. Boomsma, F. H. M. Derkx, A. J. Man In'T Veld, and M. A. D. H. Schalekamp Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME Am J Physiol Renal Physiol, December 1, 1998; 275(6): F870 - F877. [Abstract] [Full Text] [PDF]

				P.-Y. Martin, P. Gines, and R. W. Schrier Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis N. Engl. J. Med., August 20, 1998; 339(8): 533 - 541. [Full Text] [PDF]

				D. S. A. Majid, S. A. Omoro, S. Y. Chin, and L. G. Navar Intrarenal Nitric Oxide Activity and Pressure Natriuresis in Anesthetized Dogs Hypertension, August 1, 1998; 32(2): 266 - 272. [Abstract] [Full Text] [PDF]

				J. N. Bech, C. B. Nielsen, P. Ivarsen, K. T. Jensen, and E. B. Pedersen Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans Am J Physiol Renal Physiol, May 1, 1998; 274(5): F914 - F923. [Abstract] [Full Text] [PDF]

				L.-T. Dijkhorst-Oei, T. J. Rabelink, P. Boer, and H. A. Koomans Nifedipine Attenuates Systemic and Renal Vasoconstriction During Nitric Oxide Inhibition in Humans Hypertension, May 1, 1997; 29(5): 1192 - 1198. [Abstract] [Full Text]